{"gene":"MED21","run_date":"2026-04-28T18:30:28","timeline":{"discoveries":[{"year":1998,"finding":"Murine MED21 (SRB7) co-purifies as part of a mammalian Mediator complex that binds to the RNA polymerase II C-terminal domain (CTD) and stimulates phosphorylation of the CTD by TFIIH, identifying it as a subunit of the mammalian transcriptional Mediator.","method":"Biochemical purification, peptide sequencing, CTD binding and phosphorylation assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — direct biochemical reconstitution and functional assay, foundational paper with 258 citations","pmids":["9671713"],"is_preprint":false},{"year":1996,"finding":"Human SRB7 (MED21) protein is a component of a mammalian RNA polymerase II holoenzyme; antibodies against human SRB7 were used to purify a complex containing RNAPII, TFIIE, and TFIIH that is more responsive to transcriptional activators than core RNAPII.","method":"Immunopurification with anti-SRB7 antibodies, transcription assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — reciprocal immunopurification with functional transcription assay, 131 citations","pmids":["8598913"],"is_preprint":false},{"year":1998,"finding":"Human SRB7 (MED21) is a subunit of the NAT complex (containing homologs of yeast Srb7, Srb10, Srb11, Rgr1, and Med6) that represses activated transcription; the complex phosphorylates the CTD of RNAPII at residues distinct from those phosphorylated by TFIIH, and interacts with RNAPII in a manner not mediated by the CTD but precluded by CTD phosphorylation.","method":"Biochemical purification, CTD kinase assay, co-immunoprecipitation with RNAPII","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal biochemical assays, 194 citations","pmids":["9734358"],"is_preprint":false},{"year":1999,"finding":"Human SRB7 (MED21) is a component of the SMCC complex that can repress activator-dependent transcription or synergistically enhance it at limiting TFIIH; the complex shows direct activator interactions and can act independently of the RNAPII CTD.","method":"Biochemical purification, in vitro transcription assays, activator interaction assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 — reconstituted transcription assays with purified complex, 232 citations","pmids":["10024883"],"is_preprint":false},{"year":1999,"finding":"Murine Srb7 (MED21) gene is single-copy and ubiquitously expressed; disruption in embryonic stem cells revealed it is essential for cell viability and murine embryonic development, and murine Srb7 associates exclusively with high molecular weight forms of RNA polymerase II in extracts.","method":"Northern blot, gene disruption (KO) in ES cells, co-fractionation with RNAPII","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined viability phenotype plus biochemical fractionation, 59 citations","pmids":["10500093"],"is_preprint":false},{"year":1999,"finding":"Human SRB7 (MED21) is an integral component of an RNA polymerase II-SRB complex: anti-SRB7 antibody immunoprecipitates hTRFP and RNAPII, and reciprocally anti-hTRFP immunoprecipitates RNAPII and SRB7; the complex supports basal transcription and enhances Gal4-VP16-activated transcription in the presence of PC4.","method":"Reciprocal co-immunoprecipitation, in vitro transcription assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP plus functional transcription reconstitution","pmids":["9933582"],"is_preprint":false},{"year":1996,"finding":"Human SRB7 (MED21) co-fractionates with CDK8, cyclin C, and E1A/VP16-associated CTD kinase activity in a ~1.5 MDa complex consistent with the RNAPII holoenzyme, indicating MED21 is part of the holoenzyme complex that viral transactivators interact with.","method":"Gel filtration chromatography, co-fractionation, immunoblotting","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2-3 — co-fractionation with functional context, single lab","pmids":["8871557"],"is_preprint":false},{"year":2005,"finding":"The MED7·MED21 (Med7·Srb7) heterodimer structure was solved at 3.0 Å by X-ray crystallography, revealing a four-helix bundle domain and a coiled-coil protrusion connected by a flexible hinge; four putative protein-binding sites allow assembly of the Mediator middle module and binding of MED6, which bridges to the Mediator head module.","method":"X-ray crystallography (3.0 Å), protein-protein interaction assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with functional validation of MED6 bridging interaction","pmids":["15710619"],"is_preprint":false},{"year":2013,"finding":"A 3D model of the Mediator middle module places the MED7/MED21 heterodimer as part of a central tetramer with Med4/Med9, flanked by Med10 and Med31, with the module being highly extended and flexible, based on lysine-lysine cross-links mapped by mass spectrometry.","method":"Chemical cross-linking mass spectrometry, homology modeling","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 — cross-linking MS providing structural model, single lab","pmids":["23939621"],"is_preprint":false},{"year":2016,"finding":"The integrity of the conserved hinge in the MED21-MED7 heterodimer is required for human Mediator binding to RNA polymerase II to form the holoenzyme; point mutations in the hinge leave core Mediator intact but cause increased disorder of the middle module and markedly reduced affinity for Pol II.","method":"Biochemistry (co-purification, affinity assays), site-directed mutagenesis, electron microscopy","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — mutagenesis combined with biochemical and EM analysis, direct mechanistic demonstration","pmids":["27821593"],"is_preprint":false},{"year":2002,"finding":"In yeast, LexA-Srb7 (Med21) fusion is a cryptic transcriptional activator that becomes active in the absence of Srb8, Srb10, Srb11, or Sin4, and is stably associated with Med4 and Med8 when incorporated into Mediator, suggesting functional interactions within the complex.","method":"Transcriptional activation assays with LexA fusions, co-immunoprecipitation of tagged proteins","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2-3 — genetic and biochemical analysis in yeast ortholog, single lab","pmids":["12468546"],"is_preprint":false},{"year":2006,"finding":"Yeast Med21 (Srb7) interacts with Mediator subunits Med7, Med10, and Med4 (confirmed by co-immunoprecipitation of tagged proteins from insect cells and E. coli), and these interactions depend strongly on amino acid residues 2-8 of Med21; Med21 also interacts with Med6 and the co-repressor Tup1, suggesting Med21 serves as a molecular switchboard integrating signals.","method":"Two-hybrid assay, co-immunoprecipitation of recombinant tagged proteins from insect cells and E. coli, high-copy suppressor screen","journal":"Molecular genetics and genomics : MGG","confidence":"Medium","confidence_rationale":"Tier 2 — multiple interaction methods with domain mapping, single lab","pmids":["16758199"],"is_preprint":false},{"year":2012,"finding":"Yeast Med21 mutations (ewe alleles) severely impair heat-shock-induced expression of HSP82 by blocking Pol II elongation through the coding region without impairing Pol II recruitment to the promoter; med21 mutations also impair histone displacement from promoter and coding regions and reduce Pol II processivity on GAL1-regulated genes, implicating the middle module in regulating post-initiation steps.","method":"Genetic epistasis, chromatin immunoprecipitation (ChIP), 6-azauracil sensitivity assay","journal":"Genetics","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and genetic approaches in yeast ortholog, multiple genes and reporters tested","pmids":["22377631"],"is_preprint":false},{"year":2010,"finding":"MED21 (human) promotes keratinocyte proliferation and differentiation as part of the DRIP/Mediator complex coactivating vitamin D receptor (VDR); siRNA knockdown of MED21 caused hyperproliferation accompanied by increases in cyclin D1 and Gli mRNA, and defects in calcium-induced differentiation with decreased differentiation markers and impaired E-cadherin membrane translocation.","method":"VDR affinity bead purification, mass spectrometry, siRNA knockdown with proliferation and differentiation phenotypic readouts","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2-3 — KD with defined cellular phenotypes and biochemical purification identifying complex membership","pmids":["20520624"],"is_preprint":false},{"year":2014,"finding":"siRNA-mediated knockdown of human MED21 significantly impairs HIV-1 replication at a post-integration step, implicating MED21 in regulation of HIV transcription.","method":"siRNA knockdown, HIV replication assays, early/late transcript quantification","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 3 — KD with specific viral transcription phenotype, single lab","pmids":["25100719"],"is_preprint":false}],"current_model":"MED21 (SRB7) is an essential, ubiquitously expressed subunit of the Mediator middle module that forms a structurally critical heterodimer with MED7 via a four-helix bundle and flexible hinge; the integrity of this hinge is required for Mediator binding to RNA polymerase II to form the holoenzyme, MED21 interacts with MED6 (bridging the middle to head module) and with the co-repressor Tup1, and it contributes to both positive and negative regulation of Pol II transcription including at the elongation stage, while being essential for embryonic development in mammals."},"narrative":{"teleology":[{"year":1996,"claim":"Establishing that MED21 is a bona fide subunit of a mammalian RNA Pol II holoenzyme resolved whether yeast Mediator components have functional human counterparts and showed the holoenzyme is more responsive to activators than core Pol II.","evidence":"Immunopurification with anti-SRB7 antibodies co-precipitated RNAPII, TFIIE, and TFIIH; purified complex supported activator-enhanced transcription in vitro (human cell extracts)","pmids":["8598913","8871557"],"confidence":"High","gaps":["Precise position of MED21 within the Mediator architecture unknown","No direct demonstration of MED21 contribution distinct from other subunits"]},{"year":1998,"claim":"Discovery that MED21-containing complexes (NAT/SMCC) can both repress and activate Pol II transcription depending on context established the dual regulatory capacity of the Mediator and revealed CTD-kinase-dependent repression distinct from TFIIH.","evidence":"Biochemical purification of NAT and Mediator complexes with CTD kinase assays and reconstituted in vitro transcription (human)","pmids":["9734358","9671713","10024883"],"confidence":"High","gaps":["How MED21 itself contributes to switching between activation and repression was unclear","No structural data on MED21 contacts within the complex"]},{"year":1999,"claim":"Gene knockout demonstrated that MED21 is essential for murine cell viability and embryonic development, and that MED21 associates exclusively with high-molecular-weight Pol II complexes, confirming it functions only within the Mediator.","evidence":"Targeted gene disruption in mouse ES cells; Northern blot showing ubiquitous expression; co-fractionation of Srb7 with large Pol II complexes","pmids":["10500093","9933582"],"confidence":"High","gaps":["Stage-specific developmental role not characterized","Molecular basis of lethality unresolved"]},{"year":2005,"claim":"Solving the MED7·MED21 heterodimer crystal structure revealed the four-helix bundle and flexible hinge architecture, identifying protein-binding surfaces that organize the middle module and bridge to the head module via MED6.","evidence":"X-ray crystallography at 3.0 Å resolution with protein-protein interaction mapping (yeast proteins)","pmids":["15710619"],"confidence":"High","gaps":["Structure of the full middle module in complex with MED21 not yet determined","Functional significance of the hinge flexibility not tested"]},{"year":2006,"claim":"Systematic interaction mapping showed MED21 contacts MED7, MED4, MED10, MED6, and the co-repressor Tup1, with the N-terminal residues 2–8 critical for assembly, establishing MED21 as a molecular interaction hub within Mediator.","evidence":"Two-hybrid, co-immunoprecipitation of recombinant proteins from insect cells and E. coli, high-copy suppressor screen (yeast)","pmids":["16758199"],"confidence":"Medium","gaps":["Direct structural basis of Tup1–MED21 interaction not resolved","Whether Tup1 interaction is conserved in mammals is untested"]},{"year":2012,"claim":"Demonstrating that MED21 mutations block Pol II elongation and histone displacement without impairing promoter recruitment expanded the Mediator's role beyond initiation to post-initiation/elongation control.","evidence":"ChIP for Pol II occupancy across coding regions, 6-azauracil sensitivity, genetic epistasis with elongation factors (yeast med21 mutants)","pmids":["22377631"],"confidence":"Medium","gaps":["Mechanism by which MED21/middle module facilitates elongation is unclear","Not confirmed in mammalian system"]},{"year":2013,"claim":"Cross-linking mass spectrometry placed MED7/MED21 at the center of an extended, flexible middle-module tetramer with MED4/MED9, refining the architectural model of how MED21 organizes this module.","evidence":"Lysine–lysine chemical cross-linking with mass spectrometry and homology modeling (yeast middle module)","pmids":["23939621"],"confidence":"Medium","gaps":["Model resolution limited by cross-link distance constraints","Dynamic conformational states not captured"]},{"year":2016,"claim":"Point mutations in the MED7–MED21 hinge proved it is specifically required for Mediator–Pol II holoenzyme formation, directly linking the hinge flexibility observed crystallographically to a functional requirement for Pol II engagement.","evidence":"Site-directed mutagenesis of hinge residues, co-purification/affinity assays, and electron microscopy of human Mediator","pmids":["27821593"],"confidence":"High","gaps":["Atomic-resolution structure of hinge mutant Mediator not available","Whether hinge conformational changes are regulated in vivo is unknown"]},{"year":2010,"claim":"MED21 knockdown in keratinocytes revealed a specific physiological role in VDR-dependent transcription controlling proliferation and differentiation, linking a structural Mediator subunit to a defined receptor coactivation program.","evidence":"siRNA knockdown of MED21 in human keratinocytes with proliferation, differentiation, and gene expression readouts","pmids":["20520624"],"confidence":"Medium","gaps":["Whether effect is direct VDR coactivation vs. general transcription impairment not fully distinguished","In vivo relevance in skin biology not tested"]},{"year":2014,"claim":"MED21 knockdown impaired HIV-1 replication at a post-integration step, extending MED21's role to viral transcription regulation and identifying Mediator as a host dependency factor for HIV.","evidence":"siRNA knockdown with HIV-1 replication and transcript quantification assays (human cells)","pmids":["25100719"],"confidence":"Medium","gaps":["Direct vs. indirect role in Tat-dependent transcription not resolved","Single-lab finding without independent replication"]},{"year":null,"claim":"Key open questions include how MED21 conformational dynamics are regulated in vivo to switch between activation and repression, the structural basis of co-repressor (Tup1/TLE) recruitment through MED21, and whether MED21's elongation function operates through the same hinge-dependent mechanism that controls holoenzyme assembly.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of MED21 within the complete human Mediator–Pol II–PIC complex","Mechanism of MED21-dependent elongation control unresolved","In vivo gene-specific versus global transcription contributions of MED21 not systematically mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[7,8,9]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,2,3,12,13]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,4,13]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,2,3,12,13,14]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[4]}],"complexes":["Mediator complex (middle module)","RNA Pol II holoenzyme"],"partners":["MED7","MED6","MED4","MED10","MED9","CDK8","CCNC"],"other_free_text":[]},"mechanistic_narrative":"MED21 (SRB7) is an essential, ubiquitously expressed subunit of the Mediator middle module that functions as a central structural and regulatory node coupling RNA polymerase II to transcriptional activators and repressors. MED21 forms a four-helix-bundle heterodimer with MED7, connected by a flexible hinge whose integrity is required for Mediator–Pol II holoenzyme assembly; it also contacts MED6, bridging the middle and head modules, and interacts with the co-repressor Tup1 [PMID:15710619, PMID:27821593, PMID:16758199]. Beyond transcription initiation, MED21 promotes Pol II elongation through coding regions and facilitates histone displacement, and in mammalian keratinocytes it coactivates the vitamin D receptor to coordinate proliferation and differentiation [PMID:22377631, PMID:20520624]. Disruption of MED21 is lethal in murine embryonic stem cells, establishing it as essential for mammalian embryonic development [PMID:10500093]."},"prefetch_data":{"uniprot":{"accession":"Q13503","full_name":"Mediator of RNA polymerase II transcription subunit 21","aliases":["Mediator complex subunit 21","RNA polymerase II holoenzyme component SRB7","RNAPII complex component SRB7","hSrb7"],"length_aa":144,"mass_kda":15.6,"function":"Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q13503/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/MED21","classification":"Common Essential","n_dependent_lines":1034,"n_total_lines":1208,"dependency_fraction":0.8559602649006622},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000152944","cell_line_id":"CID000233","localizations":[{"compartment":"nuclear_punctae","grade":3},{"compartment":"nucleoplasm","grade":3}],"interactors":[{"gene":"MED10","stoichiometry":10.0},{"gene":"MED11","stoichiometry":10.0},{"gene":"MED14","stoichiometry":10.0},{"gene":"MED19","stoichiometry":10.0},{"gene":"MED7","stoichiometry":10.0},{"gene":"IXL;MED29","stoichiometry":10.0},{"gene":"MED24","stoichiometry":10.0},{"gene":"MED6","stoichiometry":10.0},{"gene":"MED22","stoichiometry":10.0},{"gene":"MED17","stoichiometry":10.0}],"url":"https://opencell.sf.czbiohub.org/target/CID000233","total_profiled":1310},"omim":[{"mim_id":"612915","title":"MEDIATOR COMPLEX SUBUNIT 20; MED20","url":"https://www.omim.org/entry/612915"},{"mim_id":"603800","title":"MEDIATOR COMPLEX SUBUNIT 21; MED21","url":"https://www.omim.org/entry/603800"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Nucleoli","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/MED21"},"hgnc":{"alias_symbol":["SRB7"],"prev_symbol":["SURB7"]},"alphafold":{"accession":"Q13503","domains":[{"cath_id":"1.10.287","chopping":"1-32_47-75","consensus_level":"medium","plddt":88.8457,"start":1,"end":75},{"cath_id":"1.20.5","chopping":"82-135","consensus_level":"medium","plddt":93.1996,"start":82,"end":135}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13503","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13503-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13503-F1-predicted_aligned_error_v6.png","plddt_mean":85.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MED21","jax_strain_url":"https://www.jax.org/strain/search?query=MED21"},"sequence":{"accession":"Q13503","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13503.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13503/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13503"}},"corpus_meta":[{"pmid":"9671713","id":"PMC_9671713","title":"Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathways.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9671713","citation_count":258,"is_preprint":false},{"pmid":"10024883","id":"PMC_10024883","title":"A novel human SRB/MED-containing cofactor complex, SMCC, involved in transcription regulation.","date":"1999","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/10024883","citation_count":232,"is_preprint":false},{"pmid":"9734358","id":"PMC_9734358","title":"NAT, a human complex containing Srb polypeptides that functions as a negative regulator of activated transcription.","date":"1998","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/9734358","citation_count":194,"is_preprint":false},{"pmid":"19286969","id":"PMC_19286969","title":"HISTONE MONOUBIQUITINATION1 interacts with a subunit of the mediator complex and regulates defense against necrotrophic fungal pathogens in Arabidopsis.","date":"2009","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/19286969","citation_count":193,"is_preprint":false},{"pmid":"8598913","id":"PMC_8598913","title":"A mammalian SRB protein associated with an RNA polymerase II holoenzyme.","date":"1996","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8598913","citation_count":131,"is_preprint":false},{"pmid":"19096501","id":"PMC_19096501","title":"Malleable machines in transcription regulation: the mediator complex.","date":"2008","source":"PLoS computational biology","url":"https://pubmed.ncbi.nlm.nih.gov/19096501","citation_count":102,"is_preprint":false},{"pmid":"14622953","id":"PMC_14622953","title":"Quantitative analysis of binding of transcription factor complex to biotinylated DNA probe by a streptavidin-agarose pulldown assay.","date":"2003","source":"Analytical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14622953","citation_count":66,"is_preprint":false},{"pmid":"17088561","id":"PMC_17088561","title":"A subunit of the mediator complex regulates vertebrate neuronal development.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17088561","citation_count":63,"is_preprint":false},{"pmid":"15710619","id":"PMC_15710619","title":"A conserved mediator hinge revealed in the structure of the MED7.MED21 (Med7.Srb7) heterodimer.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15710619","citation_count":61,"is_preprint":false},{"pmid":"10500093","id":"PMC_10500093","title":"Ubiquitous expression and embryonic requirement for RNA polymerase II coactivator subunit Srb7 in mice.","date":"1999","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/10500093","citation_count":59,"is_preprint":false},{"pmid":"14665463","id":"PMC_14665463","title":"Recruitment of Tup1-Ssn6 by yeast hypoxic genes and chromatin-independent exclusion of TATA binding protein.","date":"2003","source":"Eukaryotic cell","url":"https://pubmed.ncbi.nlm.nih.gov/14665463","citation_count":55,"is_preprint":false},{"pmid":"34075876","id":"PMC_34075876","title":"Repression by the Arabidopsis TOPLESS corepressor requires association with the core mediator complex.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/34075876","citation_count":55,"is_preprint":false},{"pmid":"8871557","id":"PMC_8871557","title":"Viral transactivators E1A and VP16 interact with a large complex that is associated with CTD kinase activity and contains CDK8.","date":"1996","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/8871557","citation_count":49,"is_preprint":false},{"pmid":"10825198","id":"PMC_10825198","title":"Artificial recruitment of TFIID, but not RNA polymerase II holoenzyme, activates transcription in mammalian cells.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10825198","citation_count":41,"is_preprint":false},{"pmid":"12759774","id":"PMC_12759774","title":"Characterization of mutations that are synthetic lethal with pol3-13, a mutated allele of DNA polymerase delta in Saccharomyces cerevisiae.","date":"2003","source":"Current genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12759774","citation_count":40,"is_preprint":false},{"pmid":"23939621","id":"PMC_23939621","title":"Model of the Mediator middle module based on protein cross-linking.","date":"2013","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/23939621","citation_count":37,"is_preprint":false},{"pmid":"23299323","id":"PMC_23299323","title":"The function of the Mediator complex in plant immunity.","date":"2013","source":"Plant signaling & behavior","url":"https://pubmed.ncbi.nlm.nih.gov/23299323","citation_count":37,"is_preprint":false},{"pmid":"22377631","id":"PMC_22377631","title":"Role of Mediator in regulating Pol II elongation and nucleosome displacement in Saccharomyces cerevisiae.","date":"2012","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22377631","citation_count":32,"is_preprint":false},{"pmid":"20520624","id":"PMC_20520624","title":"The transcriptional coactivator DRIP/mediator complex is involved in vitamin D receptor function and regulates keratinocyte proliferation and differentiation.","date":"2010","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/20520624","citation_count":30,"is_preprint":false},{"pmid":"25100719","id":"PMC_25100719","title":"Characterization of the influence of mediator complex in HIV-1 transcription.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25100719","citation_count":27,"is_preprint":false},{"pmid":"27821593","id":"PMC_27821593","title":"Role for the MED21-MED7 Hinge in Assembly of the Mediator-RNA Polymerase II Holoenzyme.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27821593","citation_count":24,"is_preprint":false},{"pmid":"12468546","id":"PMC_12468546","title":"Functional interactions within yeast mediator and evidence of differential subunit modifications.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12468546","citation_count":22,"is_preprint":false},{"pmid":"16758199","id":"PMC_16758199","title":"Functional and physical interactions within the middle domain of the yeast mediator.","date":"2006","source":"Molecular genetics and genomics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/16758199","citation_count":17,"is_preprint":false},{"pmid":"31956794","id":"PMC_31956794","title":"Whole Exome and Transcriptome RNA-Sequencing Model for the Diagnosis of Prostate Cancer.","date":"2019","source":"ACS omega","url":"https://pubmed.ncbi.nlm.nih.gov/31956794","citation_count":12,"is_preprint":false},{"pmid":"9933582","id":"PMC_9933582","title":"The human homologue of Drosophila TRF-proximal protein is associated with an RNA polymerase II-SRB complex.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9933582","citation_count":12,"is_preprint":false},{"pmid":"30559736","id":"PMC_30559736","title":"Theileria annulata Cyclophilin1 (TaCyp1) Interacts With Host Cell MED21.","date":"2018","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/30559736","citation_count":8,"is_preprint":false},{"pmid":"38046983","id":"PMC_38046983","title":"Screening of Lipid Metabolism-Related Genes as Diagnostic Indicators in Chronic Obstructive Pulmonary Disease.","date":"2023","source":"International journal of chronic obstructive pulmonary disease","url":"https://pubmed.ncbi.nlm.nih.gov/38046983","citation_count":7,"is_preprint":false},{"pmid":"11441538","id":"PMC_11441538","title":"Genomics of the human genes encoding four TAFII subunits of TFIID, the three subunits of TFIIA, as well as CDK8 and SURB7.","date":"1999","source":"Somatic cell and molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11441538","citation_count":2,"is_preprint":false},{"pmid":"39640640","id":"PMC_39640640","title":"Quantitative proteomics reveals the mechanism of endoplasmic reticulum stress-mediated pulmonary fibrosis in mice.","date":"2024","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/39640640","citation_count":2,"is_preprint":false},{"pmid":"39763940","id":"PMC_39763940","title":"A Hot-Swappable Genetic Switch: Building an inducible and trackable functional assay for the essential gene MEDIATOR 21.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39763940","citation_count":1,"is_preprint":false},{"pmid":"40340410","id":"PMC_40340410","title":"A Hot-Swappable Genetic Switch: Building an Inducible and Trackable Functional Assay for the Essential Gene MEDIATOR 21.","date":"2025","source":"ACS synthetic biology","url":"https://pubmed.ncbi.nlm.nih.gov/40340410","citation_count":1,"is_preprint":false},{"pmid":"31528310","id":"PMC_31528310","title":"Highlighted role of VEGFA in follow up of celiac disease.","date":"2019","source":"Gastroenterology and hepatology from bed to bench","url":"https://pubmed.ncbi.nlm.nih.gov/31528310","citation_count":1,"is_preprint":false},{"pmid":"41686635","id":"PMC_41686635","title":"Identification and validation of mitochondrial metabolism-ralated biomarkers in coronary heart disease.","date":"2026","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41686635","citation_count":0,"is_preprint":false},{"pmid":"41986337","id":"PMC_41986337","title":"PsAvh109 suppresses SA-triggered immunity by mimicking TPL function to disrupt mediator complex assembly.","date":"2026","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/41986337","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.11.11.684658","title":"mRNA isoform switching plays a crucial role in mural cumulus differentiation","date":"2025-11-13","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.11.684658","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":16777,"output_tokens":3279,"usd":0.049758},"stage2":{"model":"claude-opus-4-6","input_tokens":6690,"output_tokens":2473,"usd":0.142912},"total_usd":0.19267,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"Murine MED21 (SRB7) co-purifies as part of a mammalian Mediator complex that binds to the RNA polymerase II C-terminal domain (CTD) and stimulates phosphorylation of the CTD by TFIIH, identifying it as a subunit of the mammalian transcriptional Mediator.\",\n      \"method\": \"Biochemical purification, peptide sequencing, CTD binding and phosphorylation assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct biochemical reconstitution and functional assay, foundational paper with 258 citations\",\n      \"pmids\": [\"9671713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Human SRB7 (MED21) protein is a component of a mammalian RNA polymerase II holoenzyme; antibodies against human SRB7 were used to purify a complex containing RNAPII, TFIIE, and TFIIH that is more responsive to transcriptional activators than core RNAPII.\",\n      \"method\": \"Immunopurification with anti-SRB7 antibodies, transcription assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal immunopurification with functional transcription assay, 131 citations\",\n      \"pmids\": [\"8598913\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Human SRB7 (MED21) is a subunit of the NAT complex (containing homologs of yeast Srb7, Srb10, Srb11, Rgr1, and Med6) that represses activated transcription; the complex phosphorylates the CTD of RNAPII at residues distinct from those phosphorylated by TFIIH, and interacts with RNAPII in a manner not mediated by the CTD but precluded by CTD phosphorylation.\",\n      \"method\": \"Biochemical purification, CTD kinase assay, co-immunoprecipitation with RNAPII\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal biochemical assays, 194 citations\",\n      \"pmids\": [\"9734358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Human SRB7 (MED21) is a component of the SMCC complex that can repress activator-dependent transcription or synergistically enhance it at limiting TFIIH; the complex shows direct activator interactions and can act independently of the RNAPII CTD.\",\n      \"method\": \"Biochemical purification, in vitro transcription assays, activator interaction assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstituted transcription assays with purified complex, 232 citations\",\n      \"pmids\": [\"10024883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Murine Srb7 (MED21) gene is single-copy and ubiquitously expressed; disruption in embryonic stem cells revealed it is essential for cell viability and murine embryonic development, and murine Srb7 associates exclusively with high molecular weight forms of RNA polymerase II in extracts.\",\n      \"method\": \"Northern blot, gene disruption (KO) in ES cells, co-fractionation with RNAPII\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined viability phenotype plus biochemical fractionation, 59 citations\",\n      \"pmids\": [\"10500093\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Human SRB7 (MED21) is an integral component of an RNA polymerase II-SRB complex: anti-SRB7 antibody immunoprecipitates hTRFP and RNAPII, and reciprocally anti-hTRFP immunoprecipitates RNAPII and SRB7; the complex supports basal transcription and enhances Gal4-VP16-activated transcription in the presence of PC4.\",\n      \"method\": \"Reciprocal co-immunoprecipitation, in vitro transcription assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus functional transcription reconstitution\",\n      \"pmids\": [\"9933582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Human SRB7 (MED21) co-fractionates with CDK8, cyclin C, and E1A/VP16-associated CTD kinase activity in a ~1.5 MDa complex consistent with the RNAPII holoenzyme, indicating MED21 is part of the holoenzyme complex that viral transactivators interact with.\",\n      \"method\": \"Gel filtration chromatography, co-fractionation, immunoblotting\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — co-fractionation with functional context, single lab\",\n      \"pmids\": [\"8871557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The MED7·MED21 (Med7·Srb7) heterodimer structure was solved at 3.0 Å by X-ray crystallography, revealing a four-helix bundle domain and a coiled-coil protrusion connected by a flexible hinge; four putative protein-binding sites allow assembly of the Mediator middle module and binding of MED6, which bridges to the Mediator head module.\",\n      \"method\": \"X-ray crystallography (3.0 Å), protein-protein interaction assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with functional validation of MED6 bridging interaction\",\n      \"pmids\": [\"15710619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"A 3D model of the Mediator middle module places the MED7/MED21 heterodimer as part of a central tetramer with Med4/Med9, flanked by Med10 and Med31, with the module being highly extended and flexible, based on lysine-lysine cross-links mapped by mass spectrometry.\",\n      \"method\": \"Chemical cross-linking mass spectrometry, homology modeling\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cross-linking MS providing structural model, single lab\",\n      \"pmids\": [\"23939621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The integrity of the conserved hinge in the MED21-MED7 heterodimer is required for human Mediator binding to RNA polymerase II to form the holoenzyme; point mutations in the hinge leave core Mediator intact but cause increased disorder of the middle module and markedly reduced affinity for Pol II.\",\n      \"method\": \"Biochemistry (co-purification, affinity assays), site-directed mutagenesis, electron microscopy\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis combined with biochemical and EM analysis, direct mechanistic demonstration\",\n      \"pmids\": [\"27821593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"In yeast, LexA-Srb7 (Med21) fusion is a cryptic transcriptional activator that becomes active in the absence of Srb8, Srb10, Srb11, or Sin4, and is stably associated with Med4 and Med8 when incorporated into Mediator, suggesting functional interactions within the complex.\",\n      \"method\": \"Transcriptional activation assays with LexA fusions, co-immunoprecipitation of tagged proteins\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — genetic and biochemical analysis in yeast ortholog, single lab\",\n      \"pmids\": [\"12468546\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Yeast Med21 (Srb7) interacts with Mediator subunits Med7, Med10, and Med4 (confirmed by co-immunoprecipitation of tagged proteins from insect cells and E. coli), and these interactions depend strongly on amino acid residues 2-8 of Med21; Med21 also interacts with Med6 and the co-repressor Tup1, suggesting Med21 serves as a molecular switchboard integrating signals.\",\n      \"method\": \"Two-hybrid assay, co-immunoprecipitation of recombinant tagged proteins from insect cells and E. coli, high-copy suppressor screen\",\n      \"journal\": \"Molecular genetics and genomics : MGG\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple interaction methods with domain mapping, single lab\",\n      \"pmids\": [\"16758199\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Yeast Med21 mutations (ewe alleles) severely impair heat-shock-induced expression of HSP82 by blocking Pol II elongation through the coding region without impairing Pol II recruitment to the promoter; med21 mutations also impair histone displacement from promoter and coding regions and reduce Pol II processivity on GAL1-regulated genes, implicating the middle module in regulating post-initiation steps.\",\n      \"method\": \"Genetic epistasis, chromatin immunoprecipitation (ChIP), 6-azauracil sensitivity assay\",\n      \"journal\": \"Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and genetic approaches in yeast ortholog, multiple genes and reporters tested\",\n      \"pmids\": [\"22377631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"MED21 (human) promotes keratinocyte proliferation and differentiation as part of the DRIP/Mediator complex coactivating vitamin D receptor (VDR); siRNA knockdown of MED21 caused hyperproliferation accompanied by increases in cyclin D1 and Gli mRNA, and defects in calcium-induced differentiation with decreased differentiation markers and impaired E-cadherin membrane translocation.\",\n      \"method\": \"VDR affinity bead purification, mass spectrometry, siRNA knockdown with proliferation and differentiation phenotypic readouts\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — KD with defined cellular phenotypes and biochemical purification identifying complex membership\",\n      \"pmids\": [\"20520624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"siRNA-mediated knockdown of human MED21 significantly impairs HIV-1 replication at a post-integration step, implicating MED21 in regulation of HIV transcription.\",\n      \"method\": \"siRNA knockdown, HIV replication assays, early/late transcript quantification\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — KD with specific viral transcription phenotype, single lab\",\n      \"pmids\": [\"25100719\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MED21 (SRB7) is an essential, ubiquitously expressed subunit of the Mediator middle module that forms a structurally critical heterodimer with MED7 via a four-helix bundle and flexible hinge; the integrity of this hinge is required for Mediator binding to RNA polymerase II to form the holoenzyme, MED21 interacts with MED6 (bridging the middle to head module) and with the co-repressor Tup1, and it contributes to both positive and negative regulation of Pol II transcription including at the elongation stage, while being essential for embryonic development in mammals.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"MED21 (SRB7) is an essential, ubiquitously expressed subunit of the Mediator middle module that functions as a central structural and regulatory node coupling RNA polymerase II to transcriptional activators and repressors. MED21 forms a four-helix-bundle heterodimer with MED7, connected by a flexible hinge whose integrity is required for Mediator–Pol II holoenzyme assembly; it also contacts MED6, bridging the middle and head modules, and interacts with the co-repressor Tup1 [PMID:15710619, PMID:27821593, PMID:16758199]. Beyond transcription initiation, MED21 promotes Pol II elongation through coding regions and facilitates histone displacement, and in mammalian keratinocytes it coactivates the vitamin D receptor to coordinate proliferation and differentiation [PMID:22377631, PMID:20520624]. Disruption of MED21 is lethal in murine embryonic stem cells, establishing it as essential for mammalian embryonic development [PMID:10500093].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Establishing that MED21 is a bona fide subunit of a mammalian RNA Pol II holoenzyme resolved whether yeast Mediator components have functional human counterparts and showed the holoenzyme is more responsive to activators than core Pol II.\",\n      \"evidence\": \"Immunopurification with anti-SRB7 antibodies co-precipitated RNAPII, TFIIE, and TFIIH; purified complex supported activator-enhanced transcription in vitro (human cell extracts)\",\n      \"pmids\": [\"8598913\", \"8871557\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise position of MED21 within the Mediator architecture unknown\", \"No direct demonstration of MED21 contribution distinct from other subunits\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Discovery that MED21-containing complexes (NAT/SMCC) can both repress and activate Pol II transcription depending on context established the dual regulatory capacity of the Mediator and revealed CTD-kinase-dependent repression distinct from TFIIH.\",\n      \"evidence\": \"Biochemical purification of NAT and Mediator complexes with CTD kinase assays and reconstituted in vitro transcription (human)\",\n      \"pmids\": [\"9734358\", \"9671713\", \"10024883\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How MED21 itself contributes to switching between activation and repression was unclear\", \"No structural data on MED21 contacts within the complex\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Gene knockout demonstrated that MED21 is essential for murine cell viability and embryonic development, and that MED21 associates exclusively with high-molecular-weight Pol II complexes, confirming it functions only within the Mediator.\",\n      \"evidence\": \"Targeted gene disruption in mouse ES cells; Northern blot showing ubiquitous expression; co-fractionation of Srb7 with large Pol II complexes\",\n      \"pmids\": [\"10500093\", \"9933582\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stage-specific developmental role not characterized\", \"Molecular basis of lethality unresolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Solving the MED7·MED21 heterodimer crystal structure revealed the four-helix bundle and flexible hinge architecture, identifying protein-binding surfaces that organize the middle module and bridge to the head module via MED6.\",\n      \"evidence\": \"X-ray crystallography at 3.0 Å resolution with protein-protein interaction mapping (yeast proteins)\",\n      \"pmids\": [\"15710619\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the full middle module in complex with MED21 not yet determined\", \"Functional significance of the hinge flexibility not tested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Systematic interaction mapping showed MED21 contacts MED7, MED4, MED10, MED6, and the co-repressor Tup1, with the N-terminal residues 2–8 critical for assembly, establishing MED21 as a molecular interaction hub within Mediator.\",\n      \"evidence\": \"Two-hybrid, co-immunoprecipitation of recombinant proteins from insect cells and E. coli, high-copy suppressor screen (yeast)\",\n      \"pmids\": [\"16758199\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct structural basis of Tup1–MED21 interaction not resolved\", \"Whether Tup1 interaction is conserved in mammals is untested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrating that MED21 mutations block Pol II elongation and histone displacement without impairing promoter recruitment expanded the Mediator's role beyond initiation to post-initiation/elongation control.\",\n      \"evidence\": \"ChIP for Pol II occupancy across coding regions, 6-azauracil sensitivity, genetic epistasis with elongation factors (yeast med21 mutants)\",\n      \"pmids\": [\"22377631\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which MED21/middle module facilitates elongation is unclear\", \"Not confirmed in mammalian system\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Cross-linking mass spectrometry placed MED7/MED21 at the center of an extended, flexible middle-module tetramer with MED4/MED9, refining the architectural model of how MED21 organizes this module.\",\n      \"evidence\": \"Lysine–lysine chemical cross-linking with mass spectrometry and homology modeling (yeast middle module)\",\n      \"pmids\": [\"23939621\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Model resolution limited by cross-link distance constraints\", \"Dynamic conformational states not captured\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Point mutations in the MED7–MED21 hinge proved it is specifically required for Mediator–Pol II holoenzyme formation, directly linking the hinge flexibility observed crystallographically to a functional requirement for Pol II engagement.\",\n      \"evidence\": \"Site-directed mutagenesis of hinge residues, co-purification/affinity assays, and electron microscopy of human Mediator\",\n      \"pmids\": [\"27821593\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution structure of hinge mutant Mediator not available\", \"Whether hinge conformational changes are regulated in vivo is unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"MED21 knockdown in keratinocytes revealed a specific physiological role in VDR-dependent transcription controlling proliferation and differentiation, linking a structural Mediator subunit to a defined receptor coactivation program.\",\n      \"evidence\": \"siRNA knockdown of MED21 in human keratinocytes with proliferation, differentiation, and gene expression readouts\",\n      \"pmids\": [\"20520624\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether effect is direct VDR coactivation vs. general transcription impairment not fully distinguished\", \"In vivo relevance in skin biology not tested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"MED21 knockdown impaired HIV-1 replication at a post-integration step, extending MED21's role to viral transcription regulation and identifying Mediator as a host dependency factor for HIV.\",\n      \"evidence\": \"siRNA knockdown with HIV-1 replication and transcript quantification assays (human cells)\",\n      \"pmids\": [\"25100719\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs. indirect role in Tat-dependent transcription not resolved\", \"Single-lab finding without independent replication\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include how MED21 conformational dynamics are regulated in vivo to switch between activation and repression, the structural basis of co-repressor (Tup1/TLE) recruitment through MED21, and whether MED21's elongation function operates through the same hinge-dependent mechanism that controls holoenzyme assembly.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of MED21 within the complete human Mediator–Pol II–PIC complex\", \"Mechanism of MED21-dependent elongation control unresolved\", \"In vivo gene-specific versus global transcription contributions of MED21 not systematically mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [7, 8, 9]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 2, 3, 12, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 4, 13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 2, 3, 12, 13, 14]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"complexes\": [\n      \"Mediator complex (middle module)\",\n      \"RNA Pol II holoenzyme\"\n    ],\n    \"partners\": [\n      \"MED7\",\n      \"MED6\",\n      \"MED4\",\n      \"MED10\",\n      \"MED9\",\n      \"CDK8\",\n      \"CCNC\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}